Health
Oxford begins clinical trial on anti-tumor drug to treat Corona patients – AlKhaleej Today
Oxford begins clinical trial on anti-tumor drug to treat Corona patients

Thank you for reading a news about Oxford. A clinical trial on an anti-tumor drug to treat Corona patients begins, and now with details of the news
Cairo by Mohamed Salah Researchers at the University of Oxford have started a new study to explore the effectiveness of a drug adalimumab Anti-tumor (anti-TNF) As a treatment for Corona patients, especially in care homes, where a trial will be recorded AVID-CC , To be conducted by the Oxford Clinical Trials Research Unit (OCTRU) , As many as 750 pa…
-
Business19 hours ago
Warning! These ASX 200 shares were just downgraded
-
Business12 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
Business12 hours ago
This ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Business17 hours ago
2 monthly payers you’ll want to own in 2025 and beyond